Nuvectis Pharma Aktie - NVCT

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

6,34

Gebot

5,98

Fragen

8,25

Volumen

0,00 Tagesbereich 0,00

4,44 52-Wochen-Bereich 12,10

Marktkapitalisierung

148,302M

Handelsende

6,34

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

109.943

Ausgegebene Aktien

23.391.499

Dividendenrendite

Kurs-Gewinn-Verhältnis

-6,66

Gewinn pro Aktie (EPS)

-0,95

Erlöse

Nettogewinn

-22,26M

Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.nuvectis.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Nuvectis Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NVCT. The last closing price for Nuvectis Pharma was US$6,34. Over the last year, Nuvectis Pharma shares have traded in a share price range of US$ 4,44 to US$ 12,10.

Nuvectis Pharma currently has 23.391.499 shares in issue. The market capitalisation of Nuvectis Pharma is US$148,30 million. Nuvectis Pharma has a price to earnings ratio (PE ratio) of -6.66.

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-1.0204	-13.8633769904	7.3604	7.3604	5.87	60099	6.44744012	CS
4	0.53	9.12220309811	5.81	8.13	5.81	123851	7.11362562	CS
12	1.3717	27.609041322	4.9683	8.13	4.44	109943	6.22875769	CS
26	-0.506	-7.39117732983	6.846	11.8	4.44	139990	6.69889544	CS
52	-3.76	-37.2277227723	10.1	12.1	4.44	116429	6.91711028	CS
156	-1.18	-15.6914893617	7.52	20.92	4.44	72902	8.80204286	CS
260	2.39	60.5063291139	3.95	20.92	3.08	185254	7.78494322	CS

NVCT - Frequently Asked Questions (FAQ)

What is the current Nuvectis Pharma share price?

The current share price of Nuvectis Pharma is US$ 6,34

How many Nuvectis Pharma shares are in issue?

Nuvectis Pharma has 23.391.499 shares in issue

What is the market cap of Nuvectis Pharma?

The market capitalisation of Nuvectis Pharma is USD 148,3M

What is the 1 year trading range for Nuvectis Pharma share price?

Nuvectis Pharma has traded in the range of US$ 4,44 to US$ 12,10 during the past year

What is the PE ratio of Nuvectis Pharma?

The price to earnings ratio of Nuvectis Pharma is -6,66

What is the reporting currency for Nuvectis Pharma?

Nuvectis Pharma reports financial results in USD

What is the latest annual profit for Nuvectis Pharma?

The latest annual profit of Nuvectis Pharma is USD -22,26M

What is the registered address of Nuvectis Pharma?

The registered address for Nuvectis Pharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Nuvectis Pharma website address?

The website address for Nuvectis Pharma is www.nuvectis.com

Which industry sector does Nuvectis Pharma operate in?

Nuvectis Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
ARBBARB IOT Group Ltd	US$ 0,8873 (70,63%)	17,94M
CMRXChimerix Inc	US$ 8,41 (69,56%)	6,18M
TLFTandy Leather Factory Inc	US$ 4,14 (34,85%)	712
CYCUCycurion Inc	US$ 0,8443 (29,61%)	10,68M
HNVRHanover Bancorp Inc	US$ 29,99 (27,73%)	3
CUTRCutera Inc	US$ 0,16 (-49,11%)	482,97k
SYRESpyre Therapeutics Inc	US$ 13,13 (-27,94%)	23
RETOReTo Eco Solutions Inc	US$ 0,647 (-26,89%)	117,94k
ARHSArhaus Inc	US$ 7,01 (-24,30%)	89
GHRSGH Research PLC	US$ 7,21 (-23,22%)	3
NVNINVNI Group Ltd	US$ 0,303 (15,43%)	40,49M
GTIGraphjet Technology	US$ 0,1546 (12,03%)	28,75M
ARBBARB IOT Group Ltd	US$ 0,8877 (70,71%)	17,94M
CYCUCycurion Inc	US$ 0,8443 (29,61%)	10,68M
CGBSCrown LNG Holdings Ltd	US$ 0,2112 (-10,77%)	9,98M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Nuvectis Pharma Inc (NVCT) Börsenkurse

Nuvectis Pharma Inc (NVCT)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Nuvectis Pharma Inc

NVCT Neueste Nachrichten

Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 4 - Statement of changes in beneficial ownership of securities

Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

NVCT - Frequently Asked Questions (FAQ)

Beweger

NVCT Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen